Cargando…

mRNA turnover rate limits siRNA and microRNA efficacy

The microRNA pathway participates in basic cellular processes and its discovery has enabled the development of si/shRNAs as powerful investigational tools and potential therapeutics. Based on a simple kinetic model of the mRNA life cycle, we hypothesized that mRNAs with high turnover rates may be mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, Erik, Sander, Chris, Marks, Debora
Formato: Texto
Lenguaje:English
Publicado: European Molecular Biology Organization 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010119/
https://www.ncbi.nlm.nih.gov/pubmed/21081925
http://dx.doi.org/10.1038/msb.2010.89
_version_ 1782194782381015040
author Larsson, Erik
Sander, Chris
Marks, Debora
author_facet Larsson, Erik
Sander, Chris
Marks, Debora
author_sort Larsson, Erik
collection PubMed
description The microRNA pathway participates in basic cellular processes and its discovery has enabled the development of si/shRNAs as powerful investigational tools and potential therapeutics. Based on a simple kinetic model of the mRNA life cycle, we hypothesized that mRNAs with high turnover rates may be more resistant to RNAi-mediated silencing. The results of a simple reporter experiment strongly supported this hypothesis. We followed this with a genome-wide scale analysis of a rich corpus of experiments, including RT–qPCR validation data for thousands of siRNAs, siRNA/microRNA overexpression data and mRNA stability data. We find that short-lived transcripts are less affected by microRNA overexpression, suggesting that microRNA target prediction would be improved if mRNA turnover rates were considered. Similarly, short-lived transcripts are more difficult to silence using siRNAs, and our results may explain why certain transcripts are inherently recalcitrant to perturbation by small RNAs.
format Text
id pubmed-3010119
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher European Molecular Biology Organization
record_format MEDLINE/PubMed
spelling pubmed-30101192010-12-27 mRNA turnover rate limits siRNA and microRNA efficacy Larsson, Erik Sander, Chris Marks, Debora Mol Syst Biol Article The microRNA pathway participates in basic cellular processes and its discovery has enabled the development of si/shRNAs as powerful investigational tools and potential therapeutics. Based on a simple kinetic model of the mRNA life cycle, we hypothesized that mRNAs with high turnover rates may be more resistant to RNAi-mediated silencing. The results of a simple reporter experiment strongly supported this hypothesis. We followed this with a genome-wide scale analysis of a rich corpus of experiments, including RT–qPCR validation data for thousands of siRNAs, siRNA/microRNA overexpression data and mRNA stability data. We find that short-lived transcripts are less affected by microRNA overexpression, suggesting that microRNA target prediction would be improved if mRNA turnover rates were considered. Similarly, short-lived transcripts are more difficult to silence using siRNAs, and our results may explain why certain transcripts are inherently recalcitrant to perturbation by small RNAs. European Molecular Biology Organization 2010-11-16 /pmc/articles/PMC3010119/ /pubmed/21081925 http://dx.doi.org/10.1038/msb.2010.89 Text en Copyright © 2010, EMBO and Macmillan Publishers Limited https://creativecommons.org/licenses/by-nc-sa/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
spellingShingle Article
Larsson, Erik
Sander, Chris
Marks, Debora
mRNA turnover rate limits siRNA and microRNA efficacy
title mRNA turnover rate limits siRNA and microRNA efficacy
title_full mRNA turnover rate limits siRNA and microRNA efficacy
title_fullStr mRNA turnover rate limits siRNA and microRNA efficacy
title_full_unstemmed mRNA turnover rate limits siRNA and microRNA efficacy
title_short mRNA turnover rate limits siRNA and microRNA efficacy
title_sort mrna turnover rate limits sirna and microrna efficacy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010119/
https://www.ncbi.nlm.nih.gov/pubmed/21081925
http://dx.doi.org/10.1038/msb.2010.89
work_keys_str_mv AT larssonerik mrnaturnoverratelimitssirnaandmicrornaefficacy
AT sanderchris mrnaturnoverratelimitssirnaandmicrornaefficacy
AT marksdebora mrnaturnoverratelimitssirnaandmicrornaefficacy